Leaflet MYOVIEW 230mcg 230mg kit for radiopharmaceutical preparations


Indicated for: myocardial perfusion imaging

Route of administration: injectable

Substance: Tc - tetrofosmin (contrast agent)

ATC: V09GA02 (Various | Cardiovascular system | Technetium (99mtc) compounds)

Tc-99m-tetrofosmin is a radiopharmaceutical used in medical imaging to evaluate myocardial perfusion. It is commonly used in stress myocardial scans to diagnose coronary artery disease.

The medication is administered intravenously, and images are obtained using a gamma camera. It is important for patients to follow the doctor's instructions before and after the procedure.

Patients should be aware of potential adverse reactions, such as allergic reactions or discomfort at the injection site. It is important to inform the doctor of any unusual symptoms.

Side effects are rare but may include allergic reactions, nausea, or dizziness. Patients should be informed of these risks before the procedure.

General data about MYOVIEW 230mcg 230mg

  • Substance: Tc - tetrofosmin
  • Date of last drug list: 01-08-2019
  • Commercial code: W65923001
  • Concentration: 230mg
  • Pharmaceutical form: kit for radiopharmaceutical preparations
  • Quantity: 2
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: GE HEALTHCARE AS - NORVEGIA
  • Holder: GE HEALTHCARE AS - NORVEGIA
  • Number: 9655/2017/01
  • Shelf life: 35 weeks-after packaging for sale;after reconstituting the solution-12h

Pharmaceutical forms available for Tc - tetrofosmin

Concentrations available for Tc - tetrofosmin

  • 0.23mg
  • 230mcg
  • 230mg